We examined hemostatic abnormalities in 23 patients with acute myocardial infarction (AMI), 10 with pulmonary embolism (PE), and 10 with deep vein thrombosis (DVT). At the onset of AMI, plasma levels of tissue-type plasminogen activator (t-PA), PA inhibitor-I (PAI-I), fibrin-D-dimer, thrombin-antith
Diclofenac and acute myocardial infarction in patients with no major risk factors
โ Scribed by Susan S. Jick; James A. Kaye; Hershel Jick
- Book ID
- 108641888
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 93 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0306-5251
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The decision to use thrombolytic therapy in patients with acute myocardial infarction has been validated in recent large clinical trials. The identification of the high-risk patient, whether or not to use adjunctive strategies, and which patients may benefit from them are less clear. This article pr
## ABSTRACTS findings. In 7, an original diagnosis of sinus tachycardia (ST)was changed to atrial flutter (AFL) in 5, atrial tachycardia in 1, and AV nodal re-entry (AVNR) in 1. In 4, suspected AFL or atrial fibrillation (AF) was found to be ventricular tachycardia, AVNR, or multifocal atrial tach